Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy.
about
Gaucher disease: the role of the specialist on metabolic bone diseasesImiglucerase and its use for the treatment of Gaucher's diseaseRandomized, controlled trial of miglustat in Gaucher's disease type 3.An overview on bone manifestations in Gaucher disease.The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications.Gaucher disease: pathological mechanisms and modern management.Gaucher disease: new developments in treatment and etiology.Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.Bone turnover markers in patients with type 1 Gaucher disease.Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.Gaucher disease and bone manifestations.Long-term effectiveness of enzyme replacement therapy in adults with Gaucher disease: results from the NCS-LSD cohort study.A multicenter, open-label, phase III study of Abcertin in Gaucher disease.Haemorheology in Gaucher disease.Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort study
P2860
Q26775745-26E1C6F8-15B0-4141-8E9D-25453B4DEC40Q28287175-CB6D8BCB-1656-434B-9CFE-C1F8D4E03DF5Q30485096-97B602CC-18B3-400A-9D14-542DB778E823Q33393590-AA901F06-B345-4869-A638-7BE29A07D265Q33870303-7AC557D1-6C63-4F45-B722-B206B24D2C57Q34485240-6F1E87DF-6DD6-4635-8570-873DA10A7A46Q34556549-9B414B22-7303-4F23-B808-DE511A38F173Q34593914-261C4DF7-0ABC-4EAF-8997-C629A86D12CEQ36088711-989A90BB-5E3D-4199-A656-6397BB72BD36Q36562916-C928C341-C705-4FDB-888F-3F76C80B9769Q36737076-700FAF92-EA3C-495E-812B-6D7893794C6BQ38265941-0F242D0F-2B56-410A-BEDB-9BB549343498Q45284421-9B973FA1-D1F1-4944-BBB6-A57C818DC605Q47143887-EB988338-6D26-473C-8E2A-D9B0FDBC8F6AQ50757988-680B1552-B00B-4138-AB61-7EA01F546BA6Q57922197-A7946A5A-E744-4F50-9837-796BC5EE561B
P2860
Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Decreased bone density in sple ...... ng enzyme replacement therapy.
@en
Decreased bone density in sple ...... ng enzyme replacement therapy.
@nl
type
label
Decreased bone density in sple ...... ng enzyme replacement therapy.
@en
Decreased bone density in sple ...... ng enzyme replacement therapy.
@nl
prefLabel
Decreased bone density in sple ...... ng enzyme replacement therapy.
@en
Decreased bone density in sple ...... ng enzyme replacement therapy.
@nl
P2093
P356
P1476
Decreased bone density in sple ...... ng enzyme replacement therapy.
@en
P2093
Constance Kreps
Daniel I Rosenthal
Henry Mankin
James M Dambrosia
Norman W Barton
Ramnik J Xavier
Raphael Schiffmann
Suvimol C Hill
P304
P356
10.1006/BCMD.2002.0517
P577
2002-03-01T00:00:00Z